Healthy Clinical Trial
Official title:
Comparison of Intramuscular Distribution of Different Injection Volumes Via Diffusion Tensor Imaging (DTI)-A Pilot Trial
The purpose of this experimental pilot study is to assess a positive effect of higher injection volumes of fluid (physiological sodium) in the elbow-flection-muscle (M. biceps brachii) and elbow flexion and extension movements on fluid distribution in the muscle tissue.
Background:
Intramuscular application of Botulinum toxin is used as a successful therapy of many
conditions (e.g. spasticity, movement disorders, hypersecretory disorders, ophthalmic
disorders, painful conditions, pelvic floor and gastrointestinal disorders, cosmetic
applications) Clinical practice shows that even with the use of special guidance techniques
(electromyography (EMG), ultrasound, electrical stimulation) to increase accuracy of
targeting, botulinum toxin may spread to adjacent sites by diffusion. Different therapy
goals request variable diffusion of the toxin, depending on the number of muscles involved
and loss of function in the affected area, respectively. There is some evidence that larger
injection volume lead to greater distribution and a larger affected area. Thus, animal model
showed increased efficacy and decreased systemic side effects of botulinum toxin A in the
injected muscle after active or passive manipulation of muscle.
Magnetic resonance imaging (MRI) has the potential to noninvasively probe the amount and
motion of intracellular and extracellular water using different sequences. T2-weighted and
diffusion tensor sequences are especially useful in the quantification and characterization
of the chemical behaviour of water in different (animal) tissue types. To our knowledge
there has been no systematically performed in vivo MR study using these imaging techniques
in the visualization of intramuscular dilution of fluid in human subjects. However, the in
vivo effect on tissue distribution of different injection volumes and active muscle movement
in humans via DTI has never been observed.
Hypothesis:
Intramuscular distribution of common saline solutions can be non-invasively quantified by
DTI in human subjects. DTI can be used to elucidate if:
- Intramuscular distribution is favoured by larger injection volumes and
- Intramuscular distribution is facilitated by active muscle activity.
Rationale:
The effect of large injection volumes and active muscle activity after injection on
intramuscular toxin distribution and uptake remains unclear. Physiological sodium is the
carrier material of all preparations of Botulinum toxin, suggesting that physiological
sodium or natriumchlorid (NaCl) distribution is representative for toxin primary
distribution. Dynamic T2-weighted sequences may monitor the inflow and regional distribution
of the infused saline solution.
DTI can non-invasively quantify the amount and directionality of motion of protons in human
skeletal muscle and may therefore indirectly allow assumptions on the extra- and
intracellular distribution of the infused solution/substance.
Methods:
In this exploratory, investigator blinded pilot study, 10 healthy subjects will be
investigated by DTI of the musculi biceps brachii after randomised intramuscular injection
of two different injection volumes of NaCl and randomisation to active flexion and extension
in the elbow joints versus no active flexion and extension. During each injection dynamic T2
weighted magnetic resonance tomographic sequences will be performed. Subsequently diffusion
tensor sequences will be carried out at defined time points.
;
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |